Radó J P, Boer P
Int J Clin Pharmacol Biopharm. 1979 Jul;17(7):307-10.
We have investigated in eight healthy persons the effect of a single intranasal dose of 40 microgram DDAVP on plasma renin activity (PRA) in the upright posture. During normal sodium intake there were no differences in the PRA values between the time-control and DDAVP studies. However, during sodium restriction in four subjects with higher initial PRA, DDAVP induced a 40% decrease, lasting no longer than 45 minutes. There was no change in PRA after DDAVP in the other four subjects with much lower initial levels. Although no major or consistent suppressive influence could be demonstrated in the present study, in certain persons with highly stimulated initial PRA levels a transitory slight depression may be expected after a pharmacological dose of DDAVP.
我们对8名健康受试者进行了研究,观察单次经鼻给予40微克去氨加压素(DDAVP)对其直立姿势下血浆肾素活性(PRA)的影响。在正常钠摄入期间,时间对照研究和DDAVP研究的PRA值没有差异。然而,在4名初始PRA较高的受试者进行钠限制期间,DDAVP导致PRA下降40%,持续时间不超过45分钟。另外4名初始水平低得多的受试者在给予DDAVP后PRA没有变化。虽然在本研究中未显示出主要或一致的抑制作用,但在某些初始PRA水平受到高度刺激的人中,给予药理剂量的DDAVP后可能会出现短暂的轻微下降。